Cuban President Participates in Biopharmaceutical Company's Balance

Havana, April 8 (Prensa Latina) Cuban President Miguel Diaz-Canel participates in the annual balance of BioCubaFarma, a mega-company that produces and distributes a large part of the products included in the country's basic table of medicines.

BioCubaFarma, considered an industry of wide impact for the economy, has among its missions, appart from the production of medicines, equipment and high technology services.

In fact, BioCubaFarma manufactures more than 60 percent of the drugs that make up the basic table of essential medicines for dissimilar diseases, made up of 761 products, 486 of which are nationally produced.

At the same time , they locate in pharmacies, polyclinics, hospitals and institutes the reagents, diagnostic means, equipment, products for stomatological use, among others to guarantee human health.

The entity, characterized by its closed-loop line, from invention and development to production and commercialization, works on 422 projects, 393 of which are aimed at product and 29 technological, according to the most recent data provided by the institution.

On its website, the company highlights its international presence, with 765 medical records in 53 countries, and exports to more than 50 countries. It also has more than 400 projects in different stages of development and a large portfolio of inventions with 2,640 patents registered in Cuba and abroad.